Secondary cytoreductive surgery in the management of platinum-sensitive recurrent epithelial ovarian cancer

Journal of Surgical Oncology

Volumn 101, Issue 5, 2010, Pages 418-424

  Park, Jeong Yeol ^a   Eom, Jeong Min ^a   Kim, Dae Yeon ^a   Kim, Jong Hyeok ^a   Kim, Yong Man ^a   Kim, Young Tak ^a   Nam, Joo Hyun ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Epithelial ovarian cancer; Optimal debulking; Recurrent ovarian cancer; Secondary cytoreduction

Indexed keywords

ABDOMINAL SURGERY; ADULT; AGED; APPENDECTOMY; ARTICLE; BLEEDING; CANCER SIZE; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CHOLECYSTECTOMY; COLON RESECTION; CYSTECTOMY; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEMICOLECTOMY; HEMIHEPATECTOMY; HUMAN; HYSTERECTOMY; ILEOSTOMY; INTESTINE ANASTOMOSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; OMENTECTOMY; OVARIECTOMY; OVARY CANCER; OVERALL SURVIVAL; PANCREAS RESECTION; PELVIS LYMPHADENECTOMY; PERIOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT CANCER; REOPERATION; SALPINGOOOPHORECTOMY; SPLENECTOMY; SURVIVAL RATE; SURVIVAL TIME; THORAX SURGERY; TREATMENT OUTCOME; UNINEPHRECTOMY; URETERONEOCYSTOSTOMY;

ADULT; AGED; CISPLATIN; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS;

EID: 77950541495     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21470     Document Type: Article

References (29)

1. Zang RY, Li ZT, Tang J, et al.: Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: Who benefits? Cancer 2004;100:1152-1161.
2. McGuire WP, Hoskins WJ, Brady MF, et al.: Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996; 334:1-6.
3. Bristow RE, Tomacruz RS, Armstrong DK, et al.: Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol 2002;20:1248-1259.
4. Griffiths CT: Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 1975; 42:101-104.
5. Ozols RF: Recurrent ovarian cancer: Evidence-based treatment. J Clin Oncol 2002;20:1161-1163.
6. Berek JS, Hacker NF, Lagasse LD, et al.: Survival of patients following secondary cytoreductive surgery in ovarian cancer. Obstet Gynecol 1983;61:189-193.
7. Morris M, Gershenson DM, Wharton JT, et al.: Secondary cytoreductive surgery for recurrent epithelial ovarian cancer. Gynecol Oncol 1989;34:334-338.
8. Janicke F, Holscher M, KuhnW, et al.: Radical surgical procedure improves survival time in patients with recurrent ovarian cancer. Cancer 1992;70:2129-2136.
9. Segna RA, Dottino PR, Mandeli JP, et al.: Secondary cytoreduction for ovarian cancer following cisplatin therapy. J Clin Oncol 1993;11:434-439.
10. Vaccarello L, Rubin SC, Vlamis V, et al.: Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Gynecol Oncol 1995;57:61-65.
11. Kuhn W, Schmalfeldt B, Pache L, et al.: Disease-adapted relapse therapy for ovarian cancer: Results of a prospective study. Int J Oncol 1998;13:57-63.
12. Landoni F, Pellegrino A, Cormio G, et al.: Platin-based chemotherapy and salvage surgery in recurrent ovarian cancer following negative second-look laparotomy. Acta Obstet Gynecol Scand 1998;77:233-237.
13. Cormio G, di Vagno G, Cazzolla A, et al.: Surgical treatment of recurrent ovarian cancer: Report of 21 cases and a review of the literature. Eur J Obstet Gynecol Reprod Biol 1999;86:185-188.
14. Zang RY, Zhang ZY, Li ZT, et al.: Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer. J Surg Oncol 2000;75:24-30.
15. Gadducci A, Iacconi P, Cosio S, et al.: Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer. Gynecol Oncol 2000;79:344-349.
16. Eisenkop SM, Friedman RL, Spirtos NM: The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer 2000;88:144-153.
17. Munkarah A, Levenback C, Wolf JK, et al.: Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer. Gynecol Oncol 2001;81:237-241.
18. Scarabelli C, Gallo A, Carbone A: Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol Oncol 2001;83:504-512.
19. Tay EH, Grant PT, Gebski V, et al.: Secondary cytoreductive surgery for recurrent epithelial ovarian cancer. Obstet Gynecol 2002;99:1008-1013.
20. Zang RY, Li ZT, Zhang ZY, et al.: salvage chemotherapy for Chinese women with recurrent advanced epithelial ovarian carcinoma: A retrospective case-control study. Int J Gynecol Cancer 2003;13:419-427.
21. Onda T, Yoshikawa H, Yasugi T, et al.: Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: Proposal for patients selection. Br J Cancer 2005;92:1026-1032.
22. Gronlund B, Lundvall L, Christensen IJ, et al.: Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum. Eur J Surg Oncol 2005; 31:67-73.
23. Gungor M, Ortac F, Arvas M, et al.: The role of secondary cytoreductive surgery for recurrent ovarian cancer. Gynecol Oncol 2005;97:74-79.
24. Ayhan A, Gultekin M, Taskiran C, et al.: The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experience. Am J Obstet Gynecol 2006;194:49-56.
25. Chi DS, McCaughty K, Diaz JP, et al.: Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent: Platinum-sensitive epithelial ovarian carcinoma. Cancer 2006;106:1933-1939.
26. Tebes SJ, Sayer RA, Palmer JM, et al.: Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol Oncol 2007;106:482-487.
27. Salani R, Santillan A, Zahurak ML, et al.: Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: Analysis of prognostic factors and survival outcome. Cancer 2007;109:685-691.
28. Benedetti Panici, P, De Vivo A, Bellati F, et al.: Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer. Ann Surg Oncol 2007;14:1136-1142.
29. Munkarah AR, Coleman RL: Critical evaluation of secondary cytoreduction in recurrent ovarian cancer. Gynecol Oncol 2004;95:273-280.